top of page

The voice of Colville and northeastern Washington since 1896
|
September 15, 2026
Articles published by MarketBeat
Hesai Group Q3 Earnings Call Highlights ↗
November 10, 2026
Harrow Q3 Earnings Call Highlights ↗
November 10, 2026
Horizon Quantum Computing Pte. Q3 Earnings Call Highlights ↗
November 10, 2026
Gladstone Investment Q2 Earnings Call Highlights ↗
November 10, 2026
What Hemab Therapeutics (COAG) Said on Its Q3 Earnings Call ↗
November 10, 2026
Aviat Networks Q1 Earnings Call Highlights ↗
November 10, 2026
Autolus Therapeutics Q3 Earnings Call Highlights ↗
November 10, 2026
What Atour Lifestyle (ATAT) Said on Its Q3 Earnings Call ↗
November 10, 2026
Vir Biotechnology Hepatitis Delta Treatment Meets Phase III Goals, With 79% Virus-Free at Week 48 ↗
November 10, 2026
Via MarketBeat
Tickers
VIR
Douglas Elliman Q3 Earnings Call Highlights ↗
November 10, 2026
Groupon Q3 Earnings Call Highlights ↗
November 10, 2026
Jenoptik Q3 Earnings Call Highlights ↗
November 10, 2026
Via MarketBeat
Topics
Earnings
Via MarketBeat
Tickers
MOH
What Vodafone Group (VOD) Said on Its Q2 Earnings Call ↗
November 10, 2026
3i Infrastructure H1 Earnings Call Highlights ↗
November 10, 2026
Via MarketBeat
Topics
Earnings
What Avon Protection (AVON) Said on Its H2 Earnings Call ↗
November 10, 2026
Via MarketBeat
Topics
Earnings
TAG Immobilien Q3 Earnings Call Highlights ↗
November 10, 2026
Via MarketBeat
What Caledonia Investments (CLDN) Said on Its H1 Earnings Call ↗
November 10, 2026
Via MarketBeat
Topics
Earnings
CorMedix to Acquire Heron Assets, Adding Four Products and Targeting Up to $60 Million in Savings ↗
November 10, 2026
Via MarketBeat
Tickers
CRMD
What Oxford Instruments (OXIG) Said on Its H1 Earnings Call ↗
November 10, 2026
Via MarketBeat
Topics
Earnings
What K+S Aktiengesellschaft (SDF) Said on Its Q3 Earnings Call ↗
November 10, 2026
Via MarketBeat
Topics
Earnings
Watches of Switzerland Group Q2 Earnings Call Highlights ↗
November 10, 2026
Via MarketBeat
Topics
Earnings
KT Q3 Earnings Call Highlights ↗
November 10, 2026
Verastem Targets Accelerated Approval for Pancreatic Cancer Drug, Expands Trial Plans ↗
November 10, 2026
Via MarketBeat
Tickers
VSTM
ZipRecruiter Q3 Earnings Call Highlights ↗
November 10, 2026
WELL Health Technologies Q3 Earnings Call Highlights ↗
November 10, 2026
Celldex Therapeutics Targets 2027 Filing for Barzolvolimab After Phase 3 Results ↗
November 10, 2026
Via MarketBeat
Tickers
CLDX
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
bottom of page

